RxDoctor Payments Data

Michelle Santiago

Family · Pensacola, FLNPI 1982103552

Payments from drug & device makers

$17,659in general payments, 2019–2025

Across 1,035 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Pfizer$1K
  • Jazz Pharmaceuticals Inc.$1K
  • Novartis$1K
  • MDD US Operations, LLC$1K
  • SK Life Science, Inc.$847
  • plus $9K from 52 others

What the payments were for

  • Speaking & faculty fees$880%
  • Food & beverage$17,54099%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)217$2,526
Pfizer124$1,332
Jazz Pharmaceuticals Inc.65$1,316
Novartis77$1,137
MDD US Operations, LLC5$1,105
SK Life Science, Inc.42$847
Lilly USA, LLC27$648
Amgen(2 entities)43$610
Genentech USA, Inc.30$577
UCB, Inc.33$520
Biogen34$513
Eisai Inc.25$483
Lundbeck LLC20$413
Axsome Therapeutics, Inc.15$397
Acorda Therapeutics, Inc18$395
Acadia Pharmaceuticals Inc23$347
Argenx US, Inc.13$339
Teva Pharmaceuticals USA, Inc.26$339
Octapharma USA, Inc.13$310
AstraZeneca(2 entities)13$306
Otsuka America Pharmaceutical, Inc.12$270
Neurocrine Biosciences, Inc.11$217
Takeda Pharmaceuticals U.S.A., Inc.12$199
Boston Scientific8$187
Impel Pharmaceuticals Inc.16$183
Grifols USA, LLC9$173
Biohaven Pharmaceutical Holding Company Ltd.15$163
EMD Serono, Inc.7$158
Merck9$141
Mallinckrodt Hospital Products Inc.4$124
Alnylam Pharmaceuticals Inc.6$117
Sunovion Pharmaceuticals Inc.6$91
Arbor Pharmaceuticals, Inc.5$88
Neurelis, Inc.4$85
Merz Pharmaceuticals, LLC4$83
GE HealthCare4$81
Inspire Medical Systems, Inc.2$76
Biohaven Pharmaceuticals, Inc.3$75
Cumberland Pharmaceuticals, Inc.1$69
Catalyst Pharmaceuticals, Inc.3$57
Averitas Pharma Inc.3$52
Avadel CNS Pharmaceuticals, LLC2$52
Sanofi3$52
Kyowa Kirin, Inc.3$46
Amneal Pharmaceuticals LLC2$41
Johnson & Johnson(2 entities)2$38
Tanabe Pharma America, Inc.2$36
Harmony Biosciences LLC2$31
Xeris Pharmaceuticals, Inc.2$29
Currax Pharmaceuticals LLC2$26
Medtronic1$23
CSL Behring1$22
Upsher-smith Laboratories LLC1$22
Bristol Myers Squibb1$21
Revance Therapeutics, Inc.1$21
Akcea Therapeutics, Inc.1$19
Sumitomo Pharma America, Inc.1$17
ANI Pharmaceuticals, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,659 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$15,520
Medicare patients
133
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam11$511
Gabapentin27$300
Lamotrigine19$201

Paid to pharmacies, not to this prescriber.

Other family in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →